PEMBROBLAD: Real world effectiveness and safety of immune checkpoint inhibitors in patients with advanced urothelial carcinoma with histological variants.

被引：0
|
作者：
Amrane, Karim
Campedel, Luca
Bennamoun, Mostefa
Gabriel, Pierre-Etienne
Brouchet, Nicolas
Pouessel, Damien
Dugage, Matthieu Roulleaux
Thibault, Constance
Cancel, Mathilde
Gout, Mathilde
Flechon, Aude
Huillard, Olivier
Abbar, Baptiste
Borchiellini, Delphine
Doublet, Louis
Augusto-Pelegrin, Laetitia
Elouen, Boughalem
Moinard-Butot, Fabien
Dumont, Clement
Barthelemy, Philippe
机构：
[1] Oncol Dept, Morlaix, France
[2] CHU Clermont Ferrand, Clermont Ferrand, France
[3] Inst Mutualiste Montsouris, Paris, France
[4] Hop St Louis, Paris, France
[5] IUC Oncopole, Toulouse, France
[6] IUCT Oncopole, Inst Claudius Regaud, Toulouse, France
[7] Hop Europeen Georges Pompidou, Paris, France
[8] Univ Paris Cite, Hop Europeen Georges Pompidou, AP HP Ctr, Inst Canc Paris CARPEM,Dept Pharmacovigilance, Paris, France
[9] Univ Hosp, Dept Med Oncol, Tours, France
[10] Ctr Leon Berard, Lyon, France
[11] Univ Paris Cite, Inst Canc Paris CARPEM, Dept Med Oncol, Hop Cochin,AP HP Ctr, Paris, France
[12] Hop La Pitie Salpetriere, Paris, France
[13] Ctr Antoine Lacassagne, Nice, France
[14] Hop Prive Drome Ardeche, Valence, France
[15] CHU Rouen, Rouen, France
[16] Inst Cancerol Ouest, Angers, France
[17] ICANS Inst Cancerol Strasbourg Europe, Strasbourg, France
[18] APHP Hop St Louis, Paris, France
[19] Inst Cancerol Strasbourg Europe, Med Oncol, Strasbourg, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
261-566-9718-9794; 261-492-3532-2370-7650-2700; 261-492-2769; 613-135-244-3829; 283-9769-3573-426; 7; 3; 2; 242; 2018; 1; 38092-27449; 38092-31019; 38116-38094-8; 5;
D O I：
10.1200/JCO.2024.42.4_suppl.624
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：624 / 624
页数：1
相关论文
共 50 条
  • [21] Evidence on Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma
    Gao, Zhen
    Wang, Sichao
    Huang, Shujie
    JAMA ONCOLOGY, 2023, 9 (07) : 1004 - +
  • [22] Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: Real-world evidence
    Hein, Erica C. Koch
    Vilbert, Maysa
    Hirsch, Ian
    Ribeiro, Mauricio Fernando
    Mantle, Luke
    Fournier, Cynthia
    Butler, Marcus O.
    Spreafico, Anna
    Saibil, Samuel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice
    Kuo, Ming-Chun
    Su, Po-Jung
    Huang, Chun-Chieh
    Luo, Hao-Lun
    Chiu, Tai-Jan
    Li, Shau-Hsuan
    Wu, Chia-Che
    Liu, Ting-Ting
    Cheng, Yuan-Tso
    Kang, Chih-Hsiung
    Su, Yu-Li
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [24] A Real-World Comparison of the Safety Profile for Immune Checkpoint Inhibitors in Oncology Patients
    Alwhaibi, Abdulrahman
    Alenazi, Miteb A.
    Alghadeer, Sultan
    Mansy, Wael
    Alsaif, Reem A.
    Abualreesh, Nawaf E.
    Alanazi, Rakan J.
    Alroumi, Abdullah
    Alanazi, Saleh A.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [25] Safety and Effectiveness of Immune Checkpoint Inhibitors in Older Patients with Cancer: A Systematic Review of 48 Real-World Studies
    Andrea Luciani
    Antonio Ghidini
    Lorenzo Dottorini
    Fausto Petrelli
    Drugs & Aging, 2021, 38 : 1055 - 1065
  • [26] Safety and Effectiveness of Immune Checkpoint Inhibitors in Older Patients with Cancer: A Systematic Review of 48 Real-World Studies
    Luciani, Andrea
    Ghidini, Antonio
    Dottorini, Lorenzo
    Petrelli, Fausto
    DRUGS & AGING, 2021, 38 (12) : 1055 - 1065
  • [27] Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
    Wang, Di
    Sun, Kai
    Wang, Tianqi
    Zhang, Dongxu
    Sun, Fengze
    Cui, Yuanshan
    Zhao, Hongwei
    Wu, Jitao
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [28] Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma
    Luke S. McLean
    Annette M. Lim
    Mathias Bressel
    Alesha A. Thai
    Danny Rischin
    Drugs & Aging, 2024, 41 : 271 - 281
  • [29] Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)
    Hanna, Glenn J.
    Ruiz, Emily S.
    LeBoeuf, Nicole R.
    Thakuria, Manisha
    Schmults, Chrysalyne D.
    Decaprio, James A.
    Silk, Ann W.
    BRITISH JOURNAL OF CANCER, 2020, 123 (10) : 1535 - 1542
  • [30] Real-world effectiveness and safety of TACE combined with lenvatinib plus immune checkpoint inhibitors in patients with BCLC-B stage hepatocellular carcinoma
    Yao, Yu
    Nong, Xiang
    Liang, Jing-Chang
    Zhang, Yu-Mei
    Zhang, Zhi-Ming
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 16 (01) : 176 - 190
12345